When did the latest reported insider share award at Roivant Sciences (ROIV) occur?

The reported insider share award occurred on July 17, 2026. On that date, director Melissa B. Epperly received 543 fully vested Common Shares under Roivant Sciences Ltd.’s Non-Employee Director Compensation Plan, increasing her directly held share position.

What was the nature of the 543-share transaction reported at Roivant Sciences (ROIV)?

The 543-share transaction was a grant or award acquisition of Common Shares, not an open-market purchase. It was issued as director compensation under Roivant Sciences Ltd.’s Non-Employee Director Compensation Plan and was fully vested on the grant date.

Roivant Sciences director awarded 543 shares

Q: What insider transaction did Roivant Sciences (ROIV) report for Melissa B. Epperly?

Melissa B. Epperly reported receiving 543 Common Shares of Roivant Sciences Ltd. as a fully vested equity award. The grant was made under the company’s Non-Employee Director Compensation Plan and is classified as a direct holding of common shares.

Q: How many Roivant Sciences (ROIV) shares does Melissa B. Epperly hold after the grant?

After the grant, Melissa B. Epperly holds 17,017 Common Shares of Roivant Sciences Ltd. These shares are reported as directly owned and include the 543 Common Shares awarded on July 17, 2026 under the Non-Employee Director Compensation Plan.

Q: Was the Roivant Sciences (ROIV) insider transaction part of a director compensation program?

Yes. The transaction reflects an award of Common Shares received under Roivant Sciences Ltd.’s Non-Employee Director Compensation Plan. The footnote specifies that the shares were granted as director compensation and were fully vested when granted.

Epperly Melissa B, reported acquisition or exercise transactions in this Form 4 filing.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Epperly Melissa B, reported acquisition or exercise transactions in this Form 4 filing.

Roivant Sciences Ltd. director Melissa B. Epperly received a grant of 543 Common Shares on July 17, 2026 under the company’s Non-Employee Director Compensation Plan. The award was fully vested at grant and increased her directly held stake to 17,017 Common Shares.

Insider Trade Summary

Grant/Award: 543 shares

Grant/Award 1 txn

Insider Epperly Melissa B,

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares ^F1	543	$0.00	$0.00

Holdings After Transaction: Common Shares — 17,017 shares (Direct)

Footnotes (1)

F1. Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

Key Figures

Shares awarded: 543 Common Shares Holdings after transaction: 17,017 Common Shares Reported transaction price: 0.0000 per share +1 more

4 metrics

Shares awarded 543 Common Shares Equity award to director on 2026-07-17

Holdings after transaction 17,017 Common Shares Direct ownership by Melissa B. Epperly following award

Reported transaction price 0.0000 per share Grant/award acquisition of Common Shares

Transaction date 2026-07-17 Grant date of Common Share award

Key Terms

Non-Employee Director Compensation Plan, Common Shares, fully vested, Power of Attorney

4 terms

Non-Employee Director Compensation Plan financial

"received pursuant to the Issuer's Non-Employee Director Compensation Plan"

Common Shares financial

"Reflects an award of Common Shares received pursuant to the Issuer's"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

fully vested financial

"that was fully vested as of the grant date"

Power of Attorney regulatory

"Exhibit 24 - Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Roivant Sciences (ROIV) report for Melissa B. Epperly?

Melissa B. Epperly reported receiving 543 Common Shares of Roivant Sciences Ltd. as a fully vested equity award. The grant was made under the company’s Non-Employee Director Compensation Plan and is classified as a direct holding of common shares.

How many Roivant Sciences (ROIV) shares does Melissa B. Epperly hold after the grant?

After the grant, Melissa B. Epperly holds 17,017 Common Shares of Roivant Sciences Ltd. These shares are reported as directly owned and include the 543 Common Shares awarded on July 17, 2026 under the Non-Employee Director Compensation Plan.

Was the Roivant Sciences (ROIV) insider transaction part of a director compensation program?

Yes. The transaction reflects an award of Common Shares received under Roivant Sciences Ltd.’s Non-Employee Director Compensation Plan. The footnote specifies that the shares were granted as director compensation and were fully vested when granted.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/21/2026 - 09:00 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Epperly Melissa B,

(Last)

(First)

(Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON

SW1H 0DB

(City)

(State)

(Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	07/17/2026		A		543⁽¹⁾	A	$0⁽¹⁾	17,017	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

Remarks:

Exhibit 24 - Power of Attorney

	By: /s/ Sam Kaplan, as Attorney-in-Fact for Melissa Epperly	07/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR